Articles tagged with "GW Pharma"
8 total articles - Page 1 of 1
DEA loosens rules on prescription CBD drug Epidiolex
David Downs - Published on April 6, 2020Read morePrescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year.
Is CBD Oil Legal Now? With Epidiolex Approved, It’s Still Not Clear
Ben Adlin - Published on June 25, 2018Read moreThe FDA just approved the CBD drug Epidiolex. Here’s what that means for the legal status of CBD oil nationwide.
Study Finds CBD Drug Epidiolex Reduces Seizures by 42%
Ryan Basen - Published on May 16, 2018Read moreHigh daily doses of CBD significantly reduced seizures in patients with Lennox-Gastaut syndrome.
![]()
Cannabis Investing: Does Revenue Even Matter?
Alan Brochstein, The Cannabis Capitalist - Published on November 6, 2017Read moreRevenue generation isn’t always rewarded by the stock market. Here’s how to read revenue figures, and why you should dive deeper before investing.
![]()
South Dakota House Blunts GW Pharma Bill
Bruce Barcott - Published on March 2, 2017Read moreThe bill would have given GW a temporary monopoly on CBD in the state. New language moves all forms of CBD to Schedule IV.
![]()
GW Pharma Responds: ‘Not Creating a Monopoly’
Bruce Barcott - Published on February 22, 2017Read moreThe pharmaceutical developer says it’s pioneering markets, not elbowing out competitors.
![]()
Leafly Exclusive: GW Pharma Is Moving CBD Bills on the Down Low
Bruce Barcott - Published on February 17, 2017Read moreThe proposed state measures would give the British pharma company’s new drug–but not other CBD products–legal status.
![]()
The Shake: Denver Has Growhouse Brokers, and Miami Cops Bust Man with Majestic Half-Beard
Lisa Rough - Published on April 25, 2016Read moreLegalization advocates are at the White House today, a Utah study shows further potential for cannabis epilepsy treatment, and seriously, this guy’s beard.
